Applied DNA Sciences Inc ROE 2010-2024 | APDN
Current and historical return on equity (ROE) values for Applied DNA Sciences Inc (APDN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Applied DNA Sciences Inc ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-12-31 |
$-0.02B |
$0.01B |
-282.35% |
| 2024-09-30 |
$-0.01B |
$0.01B |
-112.00% |
| 2024-06-30 |
$-0.01B |
$0.01B |
-152.38% |
| 2024-03-31 |
$-0.01B |
$0.00B |
-325.00% |
| 2023-12-31 |
$-0.01B |
$0.00B |
-107.69% |
| 2023-09-30 |
$-0.01B |
$0.01B |
-129.03% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-71.79% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-51.28% |
| 2022-12-31 |
$-0.01B |
$0.01B |
-86.49% |
| 2022-09-30 |
$-0.01B |
$0.01B |
-100.00% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-152.94% |
| 2022-03-31 |
$-0.02B |
$0.01B |
-139.53% |
| 2021-12-31 |
$-0.02B |
$0.01B |
-111.11% |
| 2021-09-30 |
$-0.02B |
$0.01B |
-115.38% |
| 2021-06-30 |
$-0.01B |
$0.02B |
-119.15% |
| 2021-03-31 |
$-0.01B |
$0.02B |
-140.00% |
| 2020-12-31 |
$-0.02B |
$0.01B |
-214.29% |
| 2020-09-30 |
$-0.01B |
$0.01B |
-179.31% |
| 2020-06-30 |
$-0.01B |
$0.01B |
-200.00% |
| 2020-03-31 |
$-0.01B |
$0.01B |
-327.27% |
| 2019-12-31 |
$-0.01B |
$0.01B |
-1200.00% |
| 2019-09-30 |
$-0.01B |
$0.00B |
1200.00% |
| 2019-06-30 |
$-0.01B |
$0.00B |
4000.00% |
| 2019-03-31 |
$-0.01B |
$0.00B |
-1200.00% |
| 2018-12-31 |
$-0.01B |
$0.00B |
-400.00% |
| 2018-09-30 |
$-0.01B |
$0.00B |
-244.44% |
| 2018-06-30 |
$-0.01B |
$0.00B |
-183.33% |
| 2018-03-31 |
$-0.01B |
$0.01B |
-151.72% |
| 2017-12-31 |
$-0.01B |
$0.01B |
-150.00% |
| 2017-09-30 |
$-0.01B |
$0.01B |
-144.44% |
| 2017-06-30 |
$-0.01B |
$0.01B |
-123.08% |
| 2017-03-31 |
$-0.01B |
$0.01B |
-111.63% |
| 2016-12-31 |
$-0.01B |
$0.01B |
-97.96% |
| 2016-09-30 |
$-0.01B |
$0.01B |
-80.00% |
| 2016-06-30 |
$-0.01B |
$0.01B |
-62.07% |
| 2016-03-31 |
$-0.01B |
$0.02B |
-54.24% |
| 2015-12-31 |
$-0.01B |
$0.02B |
-60.87% |
| 2015-09-30 |
$-0.01B |
$0.01B |
-154.84% |
| 2015-06-30 |
$-0.01B |
$0.01B |
-329.41% |
| 2015-03-31 |
$-0.01B |
$0.00B |
-1400.00% |
| 2014-12-31 |
$-0.02B |
$0.00B |
-3000.00% |
| 2014-09-30 |
$-0.01B |
$0.00B |
-5200.00% |
| 2014-06-30 |
$-0.02B |
$0.00B |
-857.14% |
| 2014-03-31 |
$-0.02B |
$0.00B |
-666.67% |
| 2013-12-31 |
$-0.02B |
$0.00B |
-1200.00% |
| 2013-09-30 |
$-0.02B |
$0.01B |
1800.00% |
| 2013-06-30 |
$-0.02B |
$0.00B |
800.00% |
| 2013-03-31 |
$-0.02B |
$0.00B |
666.67% |
| 2012-12-31 |
$-0.01B |
$-0.01B |
1400.00% |
| 2012-09-30 |
$-0.01B |
$0.00B |
-1400.00% |
| 2012-06-30 |
$-0.01B |
$0.00B |
0.00% |
| 2012-03-31 |
$-0.01B |
$0.00B |
800.00% |
| 2011-12-31 |
$-0.01B |
$0.00B |
550.00% |
| 2011-09-30 |
$-0.01B |
$0.00B |
444.44% |
| 2011-06-30 |
$-0.01B |
$0.00B |
320.00% |
| 2011-03-31 |
$-0.01B |
$0.00B |
400.00% |
| 2010-12-31 |
$-0.01B |
$0.00B |
280.00% |
| 2010-09-30 |
$-0.01B |
$0.00B |
290.91% |
| 2010-06-30 |
$-0.01B |
$0.00B |
254.55% |
| 2010-03-31 |
$-0.01B |
$0.00B |
222.22% |
| 2009-12-31 |
$0.01B |
$0.00B |
-400.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.009B |
$0.003B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
